BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1494909)

  • 1. Genetic aspects of dopamine receptor binding in the mouse and rat brain: an overview.
    Vadasz C; Laszlovszky I; De Simone PA; Fleischer A
    J Neurochem; 1992 Sep; 59(3):793-808. PubMed ID: 1494909
    [No Abstract]   [Full Text] [Related]  

  • 2. [3H]SCH23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system.
    Schulz DW; Wyrick SD; Mailman RB
    Eur J Pharmacol; 1984 Oct; 106(1):211-2. PubMed ID: 6397360
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative autoradiographic localization of the dopamine transport complex in the rat brain: use of a highly selective radioligand: [3H]GBR 12935.
    Dawson TM; Gehlert DR; Wamsley JK
    Eur J Pharmacol; 1986 Jul; 126(1-2):171-3. PubMed ID: 3758162
    [No Abstract]   [Full Text] [Related]  

  • 4. [The distribution of dopamine D1 and D2 receptors in the brain of rodents and carnivores].
    Avgustinovich DF; Nikulina EM
    Zh Evol Biokhim Fiziol; 1992; 28(1):3-8. PubMed ID: 1387995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturational aspects of the dopaminergic system: ontogenesis of high affinity dopamine binding to neural membrane fragments of the rat brain.
    Karakiulakis G; Paradelis AG; Papaioannidou PG; Thomas PJ
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):685-94. PubMed ID: 6672486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptics and their metabolites binding to alpha 1 and D2 receptors.
    Osman OT; Becker RE
    Biol Psychiatry; 1988 Nov; 24(7):815-8. PubMed ID: 2906546
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
    Neve KA; Henningsen RA; Kinzie JM; De Paulis T; Schmidt DE; Kessler RM; Janowsky A
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1108-16. PubMed ID: 2138666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
    Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
    Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic control of dopamine and serotonin receptors in brain regions of inbred mice.
    Boehme RE; Ciaranello RD
    Brain Res; 1983 Apr; 266(1):51-65. PubMed ID: 6850346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the expression, transcription and genomic organization of D2 dopamine receptors in outbred and inbred strains of rat.
    Luedtke RR; Artymyshyn RP; Monks BR; Molinoff PB
    Brain Res; 1992 Jul; 584(1-2):45-54. PubMed ID: 1355393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
    Schulz DW; Stanford EJ; Wyrick SW; Mailman RB
    J Neurochem; 1985 Nov; 45(5):1601-11. PubMed ID: 2864398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues.
    Martres MP; Sokoloff P; Giros B; Schwartz JC
    J Neurochem; 1992 Feb; 58(2):673-9. PubMed ID: 1309568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of dopamine receptor ligands with subtypes of the opiate receptor.
    Boublik JH; Funder JW
    Eur J Pharmacol; 1984 Dec; 107(1):11-6. PubMed ID: 6098481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic evidence for the occlusion of rat brain dopamine D3 receptors in vivo.
    Schotte A; Janssen PF; Gommeren W; Luyten WH; Leysen JE
    Eur J Pharmacol; 1992 Aug; 218(2-3):373-5. PubMed ID: 1425949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for the existence of interactions between receptors for dopamine and neurotensin. Dopamine reduces the affinity and increases the number of [3H]-neurotensin binding sites in the subcortical limbic forebrain of the rat.
    Agnati LF; Fuxe K; Battistini N; Giardino L; Benfenati F; Martire M; Ruggeri M
    Acta Physiol Scand; 1985 May; 124(1):125-8. PubMed ID: 2990164
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterogeneity and regulation of central dopamine receptor subtypes studied by cDNA cloning methodology.
    Sokoloff P; Martres MP; Giros B; Bouthenet ML; Schwartz JC
    Neurochem Int; 1992 Mar; 20 Suppl():27S-32S. PubMed ID: 1365440
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative autoradiographic localization of central dopamine D-1 and D-2 receptors.
    Dawson TM; Gehlert DR; Wamsley JK
    Adv Exp Med Biol; 1986; 204():93-118. PubMed ID: 2947431
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of thiazole and isothiazole derived apomorphines.
    Sipos A; Mueller FK; Lehmann J; Berényi S; Antus S
    Arch Pharm (Weinheim); 2009 Oct; 342(10):557-68. PubMed ID: 19714675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 20. [Genotypic differences in the metabolism of brain dopamine and in the dopamine-dependent forms of behavior in mice].
    Skrinskaia IuA; Nikulina EM
    Genetika; 1988 Jul; 24(7):1321-4. PubMed ID: 3181756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.